SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Romania
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Terapia SA (CLUJ-NAPOCA)

Main Activities: Pharmaceutical and Medicine Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Terapia SA

Headquarters
124, FABRICII ST.; CLUJ-NAPOCA; Cluj; 400632
Branch Office
IRIDE PARK Business Center, 9-9A Dimitrie Pompeiu Blvd, Building no. 20, 5th-6th Floor; Bucharest; District 2; 020 335
Status: Non-Listed
Legal Form: Public Limited Company
Operational Status: Operational
CUI: 15357398
Incorporation Date: January 1, 2004
Total Employees: 667

Tel: 00 40-264-501.500; +40264501501, 00 40-37-217.96.00

Company Description

Terapia pharma producer was set up back in 1921 in Cluj Napoca, Western Romania. The company is one of the string brands in the local pharma market. The company became a commercial company in September 1991 and starting 1996 became a private company through mass privatisation process. Terapia SA was listed and quoted into the 1st tier of the Bucharest Stock Exchange between April 1st, 1997 and March 31st, 2004, when the company was delisted from BSE and became a closed company.Due to its profitability
More

Company Analysis

According to the Individual - Non-Audited financial statement for the Year of 2011, total net operating revenues increased with 6.54%, from RON 391,376,943 to RON 416,979,263 . Operating result increased from RON 94,798,772 to RON 116,558,093 which means 22.95% change. The results of the period increased 28.02% reaching RON 95,848,848 at the end of the period against RON 74,867,468 last year. Return on equity (Net income/Total equity) went from 15.50% to 17.09%, the Return On Asset (Net income / Total Asset) went from 12.72% to 14.08% and the Net Profit Margin (Net Income/Net Sales) went from 19.13% to 22.99% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 21.38% compared to 21.93% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 5.73 to 7.89 when compared to the previous year.

Key Executives

Dragos Damian General Manager
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

680,931,837

630,738,662

Current Assets

XXX,XXX,XXX

XXX,XXX,XXX

Total Liabilities

XXX,XXX,XXX

XXX,XXX,XXX

Shareholders Equity

XXX,XXX,XXX

XXX,XXX,XXX

Current Liabilities

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in RON.
Income Statement

Total Operating Revenue

XXX,XXX,XXX

XXX,XXX,XXX

Operational Profit (Loss)

XXX,XXX,XXX

XX,XXX,XXX

Net Profit (Loss)

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in RON.
Ratios
Profitability Ratios

Return on Assets (ROA)

XX.XX%

X.XX%

Annualised Return on Assets (ROA)

XX.XX%

XX.XX%

Return on Equity (ROE)

XX.XX%

X.XX%

Annualised Return on Equity (ROE)

XX.XX%

XX.XX%

Return on Sales (ROS)

XX.XX%

XX.XX%

Return on Capital

XX.XX%

X.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

XX.XX%

XX.XX%

Efficiency Ratios

Accounts Receivable Turnover

X.XXx

X.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

X.XXx

Asset Turnover

X.XXx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

XXX,XXX,XXX

XX,XXX,XXX

EBITDA

XXX,XXX,XXX

XX,XXX,XXX

Bookvalue (BV)

XXX,XXX,XXX

XXX,XXX,XXX

Net Cash

-XX,XXX,XXX

-X,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XXX.XX%

XXX.XX%

Doom's day ratio

XX.XX%

XX.XX%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Interest Coverage Ratio

XXX.XX%

XX.XX%

Debt to equity

XX.XX%

XX.XX%

Debt to total assets

X.XX%

X.XX%